about
Conformational equilibria in monomeric alpha-synuclein at the single-molecule levelBiochemical characterization of highly purified leucine-rich repeat kinases 1 and 2 demonstrates formation of homodimersThe chaperone-like protein 14-3-3η interacts with human α-synuclein aggregation intermediates rerouting the amyloidogenic pathway and reducing α-synuclein cellular toxicityLRRK2 kinase activity regulates synaptic vesicle trafficking and neurotransmitter release through modulation of LRRK2 macro-molecular complexGTPase activity regulates kinase activity and cellular phenotypes of Parkinson's disease-associated LRRK2DJ-1 is a copper chaperone acting on SOD1 activationParkinson's disease and immune system: is the culprit LRRKing in the periphery?Anti-Oxidants in Parkinson's Disease Therapy: A Critical Point of ViewLeucine-rich repeat kinase 2 interacts with p21-activated kinase 6 to control neurite complexity in mammalian brainDifferences in the binding of copper(I) to α- and β-synucleinα-Synuclein is a Novel Microtubule Dynamase.A topological model of the interaction between alpha-synuclein and sodium dodecyl sulfate micelles.Alpha-synuclein overexpression increases dopamine toxicity in BE2-M17 cellsStructural basis of the lactate-dependent allosteric regulation of oxygen binding in arthropod hemocyaninHuman SOD2 modification by dopamine quinones affects enzymatic activity by promoting its aggregation: possible implications for Parkinson's diseaseCovalent α-synuclein dimers: chemico-physical and aggregation properties.Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies.α-Synuclein oligomers induced by docosahexaenoic acid affect membrane integrity.NADH fluorescence lifetime is an endogenous reporter of α-synuclein aggregation in live cellsAnalysis of the Catecholaminergic Phenotype in Human SH-SY5Y and BE(2)-M17 Neuroblastoma Cell Lines upon Differentiation.Dopamine-derived quinones affect the structure of the redox sensor DJ-1 through modifications at Cys-106 and Cys-53Molecular basis of the Bohr effect in arthropod hemocyaninStructural insights on physiological functions and pathological effects of alpha-synuclein.Interaction between alpha-synuclein and metal ions, still looking for a role in the pathogenesis of Parkinson's disease.DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function.Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice.Human leucine-rich repeat kinase 1 and 2: intersecting or unrelated functions?Dysfunction of dopamine homeostasis: clues in the hunt for novel Parkinson's disease therapies.Are dopamine derivatives implicated in the pathogenesis of Parkinson's disease?Biophysical groundwork as a hinge to unravel the biology of α-synuclein aggregation and toxicity.LRRK2 and neuroinflammation: partners in crime in Parkinson's disease?A novel prion protein-tyrosine hydroxylase interaction.Designed hairpin peptides interfere with amyloidogenesis pathways: fibril formation and cytotoxicity inhibition, interception of the preamyloid stateLysines, Achilles' heel in alpha-synuclein conversion to a deadly neuronal endotoxin.Are Human Tyrosinase and Related Proteins Suitable Targets for Melanoma Therapy?Superoxide Dismutase (SOD)-mimetic M40403 Is Protective in Cell and Fly Models of Paraquat Toxicity: IMPLICATIONS FOR PARKINSON DISEASE.GTP binding regulates cellular localization of Parkinson's disease-associated LRRK2.Number and Brightness analysis of alpha-synuclein oligomerization and the associated mitochondrial morphology alterations in live cells.Seasonal variation of trehalose and glycerol concentrations in winter snow-active insects.Cross-talk between LRRK2 and PKA: implication for Parkinson's disease?
P50
Q21563559-BC42BB0B-D119-4FEE-B0D8-2D3BD673A4ABQ24298093-739B0C26-78F9-4F5B-977F-AEB927319840Q24298721-D5199696-77F5-4C8E-8C75-D4E4B76AB8F7Q24298891-4283D6A9-1C3D-485E-8905-4C453B1F1A53Q24306167-A4446778-E3BD-4FE9-AEAF-25C2FEC39D37Q24338208-B10F53B4-73D7-4042-8A59-5B299807DE6EQ27687171-7775A275-3651-461E-B92F-D7EB9017DEFEQ28084254-00BEA0D7-2FB1-4F13-A04A-7F0DB30FB6AEQ28267434-BABBC8B0-415D-424A-9148-4B0B78E00B23Q28910327-FB6ECBFD-0593-46CB-834A-1C011CEC9775Q30811315-52ADAA0D-433A-4288-B0D0-A1E8DA982DB0Q30979656-463F2A4E-24FD-4051-B936-25BECF56BCF0Q33545484-7F2161F1-11B3-4A0E-ACBD-C780038DFD34Q33911357-9C7E8B1E-E863-4E2C-89B8-EA9457079865Q34313803-5EC7E080-7258-4D84-80EE-E9E7E46E634DQ34524912-584C33E5-3636-4299-A3E1-1C137E3D0044Q34576478-A3E090DC-FD57-4F2D-AD3E-1F3674D8AA90Q35060948-96387C77-078D-4683-98CD-BB521362EDF2Q35660114-860FFDA6-7008-47D4-8732-0A0CE6AB8684Q35758576-263F123D-3EF0-4978-A3E7-D5023ADF7BFDQ36002833-CBC43BB1-7C69-4883-AD48-BFA1571F57E9Q36968451-BB3AA95D-5495-46A8-B5EF-8AD77B983C14Q37307280-AD55E50D-B2FD-4B2A-8D3F-7F10F9E3A555Q37577611-D77EC2D4-5EBF-4EE8-9825-BC0CA9E8A81DQ37584540-A341F16E-7AA6-40CA-A8F2-1E1CCC15F420Q37701053-40239E61-5889-4C5E-AB9F-DFE9FAFFACDDQ38044437-90E0E603-9834-4D77-B62A-F598FFACE68FQ38086812-D0322039-14B1-4086-B332-4A91F6A5610DQ38175706-778DFFE6-9CDC-4146-9FEA-8BF7F74FCDE0Q38180144-C66CCFB6-1DAE-42C2-B6DA-77F15B0E7B74Q38198207-C75D39F9-53E0-4122-8A9B-C3A8F90F8B1CQ38228228-897CF7A7-5449-45E2-B096-83C473A7FD7AQ38542133-F7B5A473-F180-49BF-9A06-C2B2B3AA6775Q38675441-2DEC4F22-366F-450D-A82E-216AFF2012CDQ38735505-F36A2C6D-48A3-4136-A4DF-D755C5044BCDQ38787990-72317217-803E-4D58-8635-4E9C8C495212Q38814476-CE94504C-BCA4-4A8E-BC87-28273FE3B5B1Q39021697-2B53C84E-8495-4BFB-9980-62C543E1AF94Q39105763-BA3438C0-2554-48CA-A9D4-8BB15A82A232Q39137396-F59EFA57-4A29-4600-AE3A-57B5A07FE68C
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Luigi Bubacco
@ast
Luigi Bubacco
@en
Luigi Bubacco
@es
Luigi Bubacco
@sl
type
label
Luigi Bubacco
@ast
Luigi Bubacco
@en
Luigi Bubacco
@es
Luigi Bubacco
@sl
altLabel
Bubacco L
@en
prefLabel
Luigi Bubacco
@ast
Luigi Bubacco
@en
Luigi Bubacco
@es
Luigi Bubacco
@sl
P106
P1153
6701737219
P21
P2798
P31
P3835
luigi-bubacco
P4012
P496
0000-0001-7927-9208